S
Suzanne Oparil
Researcher at University of Alabama at Birmingham
Publications - 941
Citations - 122414
Suzanne Oparil is an academic researcher from University of Alabama at Birmingham. The author has contributed to research in topics: Blood pressure & Angiotensin II. The author has an hindex of 106, co-authored 885 publications receiving 113983 citations. Previous affiliations of Suzanne Oparil include Michigan State University & Oregon Health & Science University.
Papers
More filters
Journal ArticleDOI
Hormones and Vasoprotection
TL;DR: Fundamental mechanistic studies of the cellular and molecular events by which hormones protect (or fail to protect) blood vessels from damage are needed to define the role of postmenopausal hormone replacement therapy in cardiovascular disease prevention.
Journal ArticleDOI
Myocardial hypertrophy and ventricular performance in the absence of hypertension in spontaneously hypertensive rats.
TL;DR: Ventricular performance and myocardial hypertrophy were studied in maturing spontaneously hypertensive and normotensive Kyoto-Wistar rats from 4 through 24 weeks of age to suggest that myocardials may be a manifestation of an underlyingMyocardial abnormality which could account for the hemodynamic alterations found in SH rats.
Journal ArticleDOI
VEGF nanoparticles repair the heart after myocardial infarction.
Yasin Oduk,Wuqiang Zhu,Ramaswamy Kannappan,Meng Zhao,Anton V. Borovjagin,Suzanne Oparil,Jianyi Jay Zhang +6 more
TL;DR: This study provides proof of principle that nanoparticle-mediated delivery increases the angiogenic and therapeutic potency of VEGF for the treatment of ischemic heart disease.
Journal ArticleDOI
A comparison of the angiotensin II antagonists valsartan and losartan in the treatment of essential hypertension.
Thomas Hedner,Suzanne Oparil,Knud Rasmussen,Alessandro Rapelli,Marjorie Regan Gatlin,Patrizia Kobi,John Sullivan,Pascale Oddou-Stock +7 more
TL;DR: Valsartan (80/160 mg) monotherapy in this trial was as effective and well tolerated as 50/100 mg losartan in treating mild to moderate essential hypertension, and at 160 mg has a significantly higher responder rate than 100 mgLosartan.
Journal ArticleDOI
Gender and blood pressure.
Suzanne Oparil,Andrew P. Miller +1 more
TL;DR: A brief review will discuss recent findings that bear on considerations of gender in the management of hypertension, particularly among older women.